RAPP insider buying
2 cluster buysRapport Therapeutics, Inc. · Healthcare
When two or more insiders at Rapport Therapeutics, Inc. buy RAPP on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in RAPP plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Sep 12 – Sep 12, 2025Detected Sep 12, 20252 insidersTotal bought$1.5MMarket cap$1.9B
- Mar 12 – Mar 13, 2025Detected Mar 13, 2025High conviction2 insidersTotal bought$162.2KMarket cap$1.8B
All notable open-market buys in RAPP
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Sep 12, 2025 | PAUL STEVEN Mcluster Director | 28,284 | $24.50 | $693.0K | SEC ↗ |
| Sep 12, 2025 | Huber Reid Mcluster Director | 20,400 | $24.48 | $499.4K | SEC ↗ |
| Sep 12, 2025 | PAUL STEVEN Mcluster Director | 13,382 | $24.97 | $334.1K | SEC ↗ |
| Sep 11, 2025 | Director | 3,500 | $22.60 | $79.1K | SEC ↗ |
| Mar 13, 2025 | Ignelzi Troy A.cluster Chief Financial Officer | 100 | $9.98 | $998.0 | SEC ↗ |
| Mar 12, 2025 | Ignelzi Troy A.cluster Chief Financial Officer | 9,900 | $10.10 | $100.0K | SEC ↗ |
| Mar 12, 2025 | Young Wendy B.cluster Director | 6,000 | $10.21 | $61.3K | SEC ↗ |
| Jul 1, 2024 | Director | 4,878 | $25.02 | $122.0K | SEC ↗ |
| Jul 1, 2024 | Director | 4,661 | $25.02 | $116.6K | SEC ↗ |
| Jul 1, 2024 | Director | 4,544 | $25.02 | $113.7K | SEC ↗ |
| Jun 10, 2024 | Director | 470,589 | $17.00 | $8.0M | SEC ↗ |
| Jun 10, 2024 | Director | 26,278 | $17.00 | $446.7K | SEC ↗ |
| Jun 10, 2024 | Director | 25,455 | $17.00 | $432.7K | SEC ↗ |
| Jun 10, 2024 | Director | 18,641 | $17.00 | $316.9K | SEC ↗ |
| Jun 10, 2024 | Director | 17,861 | $17.00 | $303.6K | SEC ↗ |
More Healthcare stocks with insider cluster buys
RAPP insider buying — FAQ
- Are insiders buying RAPP stock?
- Yes — 5 distinct insiders have bought RAPP (Rapport Therapeutics, Inc.) on the open market, including 2 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Sep 15, 2025.
- How much RAPP stock have insiders bought?
- Insiders have bought a combined $11.6M of RAPP across 15 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in RAPP?
- A cluster buy is two or more distinct Rapport Therapeutics, Inc. insiders — officers, directors, or 10% owners — each buying RAPP on the open market within a rolling window. RAPP has 2 detected cluster buys to date.
- Where does this RAPP insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in RAPP
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy RAPP within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding RAPP.